Home › Focal Segmental Glomerulosclerosis › Kansas › Kansas City
Focal Segmental Glomerulosclerosis clinical trials in Kansas City, KS
3 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- EmVenio Research Inc. - Kansas City, Kansas City
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
NEPTUNE Match Study
Recruiting
- University of Kansas Medical Center, Kansas City
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Ann Arbor, MI6 studies
- Queens, NY6 studies
- Miami, FL6 studies
- Los Angeles, CA6 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Dallas, TX4 studies
- Chicago, IL4 studies
- Cleveland, OH4 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Interstitial Lung Diseases13 studies
- Heart Failure13 studies
- Obesity13 studies
- Cystic Fibrosis13 studies
- Bladder Cancer12 studies
- Prostate Cancer12 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.